GB virus C infection: Is there a clinical relevance for patients infected with the human immunodeficiency virus?

AIDS Reviews

Volumn 7, Issue 1, 2005, Pages 3-12

  Kaiser, Thorsten ^a   Tillmann, Hans L ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Coinfection; GBV C; HAART; Hepatitis; HGV; HIV; Interferon; Survival

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; ANTIRETROVIRUS AGENT; PEGINTERFERON; RIBAVIRIN;

COMORBIDITY; DISEASE COURSE; GENOTYPE; HEPATITIS G; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PROGNOSIS; REVIEW; SUPERINFECTION; SURVIVAL TIME; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; GB VIRUS C; GENOTYPE; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; QUALITY OF LIFE; RNA, VIRAL;

EID: 18744409542     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Ockenga J, Tillmann H, Trautwein C, Stoll M, Manns M, Schmidt R. Hepatitis B and C in HIV-infected patients: prevalence and prognostic value. J Hepatol 1997;27:18-24.
2. Nunez M, Soriano V. Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients. J Infect Dis 2005;191:1-3.
3. Tillmann H, Berning-Haag A, Elze M, et al. Longer survival of liver transplant recipients with multiple hepatitis virus infections. Hepatology 2002;36:659A.
4. Wagner-Jauregg J - Nobel Lecture; Nobel Lecture, December 13, 1927.
5. Toyoda H, Fukuda Y, Hayakawa T, et al. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr 1998;17:209-13.
6. Heringlake S, Ockenga J, Tillmann H, et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis. 1998;177:1723-6.
7. Simons J, Pilot-Matias T, Leary T, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995;92:3401-5.
8. Simons J, Leary T, Dawson G, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1:564-9.
9. Linnen J, Wages J, Zhang-Keck Z, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
10. Alter H. The cloning and clinical implications of HGV and GBV-C. N Engl J Med 1996;334:1536
11. Leary T, Muerhoff A, Simons J, et al. Sequence and genomic organisation of GBV-C: a novel member of the flaviviridae associated with human non A-E hepatitis. J Med Virol 1996;48:60-7.
12. Xiang J, Klinzman D, McLinden J, et al. Characterization of hepatitis G (GB-C Virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol 1998; 72:2738-44.
13. Rambusch E, Wedemeyer H, Tillmann H, Heringlake S, Manns M. Significance of coinfection with hepatitis G virus for chronic hepatitis C - a review of the literature. Z Gastroenterol 1998;36:41-53.
14. Stark K, Doering C, Bienzle U, et al. Risk and clearance of GB virus C/hepatitis G virus infection in homosexual men: A longitudinal study. J Med Virol 1999;59:303-6.
15. Tillmann H, Heringlake S, Trauwein C, et al. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology 1998:28:379-84.
16. Berenguer M, Terrault N, Piatak M, et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996;111:1569-75.
17. Tucker T, Smuts H, Eedes C, et al: Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus.J Med Virol 2000;61:52-8.
18. Radkowski M, Kubicka J, Kisiel E, et al. Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood. 2000;95:3986-9.
19. Fogeda M, Navas S, Martin J, et al. In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus. J Virol 1999;73:4052-61.
20. Ramia S, Mokhbat J, Sibai A, Klayme S, Naman R, HIV Epidemiology Research Study Group. Exposure rates to hepatitis C and G virus infections among HIV-infected patients: evidence of efficient transmission of HGV by the sexual route. Int J STD AIDS 2004;15:463-6.
21. Bourlet T, Berthelot P, Grattard F, et al. Detection of GB virus C/hepatitis G virus in semen and saliva of HIV type 1 infected men. Clin Microbiol Infect 2002;8:352-7.
22. Nordbo S, Krokstad S, Winge P, Skjeldestad F, Dalen A. Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors. J Clin Microbiol 2000;38:2584-90.
23. Alter H. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion. 1997;37:569-72.
24. Puig-Basagoiti F, Cabana M, Guilera M, et al. Prevalence and route of transmission of infection with a novel DNA virus (TTV), hepatitis C virus, and hepatitis G virus in patients infected with HIV. J Acquir Immune Defic Syndr 2000;23:89-94.
25. Lau D, Miller K, Detmer J, et al. Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy. J Infect Dis 1999;180:1334-37.
26. Christensen P, Fisker N, Mygind L, et al. GB virus C epidemiology in Denmark: different routes of transmission in children and low- and high-risk adults. J Med Virol 2003;70:156-62.
27. Rey D, Fraize S, Vidinic J, et al. High prevalence of GB virus C/hepatitis G virus RNA in patients infected with human immunodeficiency virus. J Med Virol 1999;57:75-9.
28. Nolte F. Branched DNA signal amplification for direct quantitation of nucleic acid sequences in clinical specimens. Adv Clin Chem 1998;33:201-35.
29. Tacke M, Kiyosawa K, Stark K, et al. Detection of antibodies to a putative hepatitis G Virus envelope protein. Lancet 1997;349:318-20.
30. Dille B, Surowy T, Gutierrez R, et al. An Elisa for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 1997;175:458-61.
31. Nubling C, Bialleck H, Fursch A, et al. Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations. J Med Virol 1997;53:218-24.
32. Williams C, Klinzman D, Yamashita T, et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med. 2004; 350:981-90.
33. Tillmann H, Heringlake S, Trautwein C, et al. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology 1998; 28:379-84.
34. Silini E, Belli L, Alberti A, et al. HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infection. J Hepatol 1998;29:533-40.
35. Tillmann H, Heiken H, Knapik-Botor A, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001;345:715-24.
36. Devereux H, Sabin CA, Kinson Z, et al. Influence of HIV-1 infection on GBV-C infection in multiply infected haemophilic patients. J Med Virol 1998;56:316-20.
37. Tillmann H, Manns M. GB virus-C infection in patients infected with the human immunodeficiency virus. Antiviral Res 2001;52:83-90.
38. Lefrere J, Roudot-Thoraval F, Morand-Joubert L, et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179:783-9.
39. Yea A, Matsumoto A, Hisada M, et al. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med 2000; 132:959-63.
40. Xiang J, Wunschmann S, Diekema D, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med. 2001;345:707-14.
41. Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 2002;16:2482-5.
42. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004; 18:877-86.
43. Sabin C, Devereux H, Kinson Z, et al. Effect of coinfection with hepatitis G virus on HIV disease progression in hemophilic men. J Acquir Immune Defic Syndr 1998;19:546-8.
44. Kaye S, Howard M, Alabi A, Hansmann A, Whittle H, van der Loeff H. No observed effect of GB virus C coinfection in disease progression in a cohort of African woman infected with IV-1 and HIV-2. Clin Infect Dis 2005;40:876-8.
45. Williams C, Allen J, Benning L, et al. Prevalence, Acquisition, and Clearance of GB Virus Type C in the Women's Interagency HIV Study. 12th Conference on Retroviruses and Opportunistic Infections, February 22-25, 2005.
46. Van der Bij A, Kloosterboer N, Prins M, et al. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis 2005;191:678-85.
47. Voirin N, Trepo C, Esteve J, et al. Effects of co-infection with hepatitis C virus and GB virus C on CD4 cell count and HIV-RNA level among HIV-infected patients treated with highly active antiretroviral therapy. AIDS 2002;16:1556-9.
48. Rodriguez B, Woolley I, Lederman M, Zdunek D, Hess G, Valdez H. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients. J Infect Dis 2003;187:504-7.
49. Souza I, Zhang W, Diaz R, Chaloner K, Klinzman D, Stapleton J. Effect of GB Virus C (GBV-C) on antiretroviral therapy (ART). IDSA, Boston, MA. Sept. 28-30, 2004.
50. Antonucci G, Girardi E, Cozzi-Lepri A, et al. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. Antivir Ther 2005;10:109-17.
51. Brumme Z, Chan K, Dong W, et al. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy. AIDS 2002;16:1929-33.
52. Tillmann H, Kaiser T, Fox Z, et al. Presence of GB virus-C and response to HAART, analysed within the maxCmin1 trial comparing the efficacy and safety of indinavir/ritonavir versus saquinavir/ritonavir. 2nd IAS Conference on HIV Pathogenesis and Treatment, Paris, France, 13-16 July, 2003.
53. Dragsted U, Gerstoft J, Pedersen C, et al. Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial. J Infect Dis 2003;188:635-42.
54. Tillmann H, Stoll M, Manns M, Schmidt R, Heiken H. Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients. AIDS 2002;16:808-9.
55. Nattermann J, Nischalke H, Kupfer B, et al: Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 2003; 17:1457-62.
56. Xiang J, George S, Wunschmann S, Chang Q, Klinzman D, Stapleton J. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 2004;363:2040-6.
57. Kaufman T, McLinden J, Xiang J, et al: Interaction between GB Virus C envelope Glycoprotein E2 and cell lines. 12th Conference on Retroviruses and Opportunistic Infections, February 22-25, 2005.
58. Xiang J, McLinden J, Chang Q, Kaufman T, Stapleton J. GB Virus C NS5A Protein Expression Decreases HIV Replication in Jurkat Cells. 12th Conference on Retroviruses and Opportunistic Infections, February 22-25, 2005.
59. Nunnari G, Nigro L, Palermo F, et al. Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 2003;139:26-30.
60. Perkins M, Rathod A, Chigubo J, et al. Evaluation of HIV-1- and GBV-C-specific T-cell Responses in Individuals Co-infected with HIV-1 and GB Virus C. 12th Conference on Retroviruses and Opportunistic Infections, February 22-25, 2005.
61. Rambusch E, Wedemeyer H, Tillmann H, Heringlake S, Manns M. Die Bedeutung einer Koinfektion mit dem Hepatitis-G-Virus für die chronische Hepatitis C - ein Review der Literatur. Z Gastroenterol 1998;36:41-53.
62. Schwarze-Zander C, Blackard J. GBV-C clearance in HIV/HCV co-infected patients receiving interferon and ribavirin therapy. 1st Int Workshop on HIV and Hepatitis Co-infection, Amsterdam, The Netherlands, 2-4 December 2004 [abstract 22].
63. Muerhoff A, Tillmann H, Manns M, Dawson G, Desai S. GB virus C genotype determination in GB virus-C/HIV co-infected individuals. J Med Virol 2003;70:141-9.
64. George S, Xiang J, Stapleton J. Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology 2003;316:191-201.
65. Knauer O, Donhauser P, Jung S, Fleckenstein B, Reil H. Strong inhibition of HIV replication by GBV-C in vitro. Annual Meeting of the "Gesellschaft für Virologie", Tübingen, Germany March 17-20 [abstract 509].
66. Tillmann H, Manns M, Claes C, Heiken H, Schmidt R, Stoll M. GB virus C infection and quality of life in HIV-positive patients. AIDS Care 2004;16:736-43.
67. Weintrob A, Hamilton J, Hahn C, et al: Active or prior GB virus C infection does not protect against vertical transmission of HIV in coinfected women from Tanzania. Clin Infect Dis 2004;38:e46-8.
68. Barqasho B, Naver L, Bohlin A, Lindgren S, Hultgren C, Birk M. GB virus C coinfection and vertical transmission in HIV-infected mothers before the introduction of antiretroviral prophylaxis. HIV Med 2004; 5:427-30.
69. Sathar M, York D, Gouws E, Coutsoudis A, Coovadia H. GB virus type C coinfection in HIV-infected African mothers and their infants, KwaZulu Natal, South Africa. Clin Infect Dis. 2004;38:405-9.
70. Bisson G, Stapleton J, Gross R, et al. GB virus C viremia is frequently acquired near HIV seroconversion, but does not protect against HIV acquisition nor lower HIV viral load set point. 12th Conference on Retroviruses and Opportunistic Infections, February 22-25, 2005.
71. Thompson J, Higgins D, Gibson T. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-80.
72. Page R. TreeView: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 1996;12:357-8.